We are live on ! Find out more
FCMV

Foresite Capital Management V Portfolio holdings

AUM $271M
1-Year Est. Return 309.87%
This Fund
S&P 500
This Quarter Est. Return
+42.14%
1 Year Est. Return
+309.87%
3 Year Est. Return
+356.88%
5 Year Est. Return
+250.56%
10 Year Est. Return
–
AUM
$109M
AUM Growth
+$28M
Cap. Flow
-$3.57M
Cap. Flow %
-3.28%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
LYEL icon
Lyell Immunopharma
LYEL
+$804K

Top Sells

Rank Stock Value
1
MAZE
Maze Therapeutics
MAZE
+$4.37M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGON icon
1
CG Oncology
CGON
$6.11B
$40.4M 37.19%
1,004,050
– –
ALMS
2
Alumis Inc
ALMS
$3.57B
$23.1M 21.21%
5,779,348
– –
IRON icon
3
Disc Medicine
IRON
$2.83B
$19.8M 18.17%
299,069
– –
HIMS icon
4
Hims & Hers Health
HIMS
$6.5B
$15.5M 14.25%
273,151
– –
LYEL icon
5
Lyell Immunopharma
LYEL
$309M
$7.75M 7.12%
477,078
+70,426
+17% +$804K
MAZE
6
Maze Therapeutics
MAZE
$1.53B
$2.24M 2.06%
86,291
-258,900
-75% -$4.37M

Similar funds

MAM
Mullooly Asset Management Wall Township, New Jersey $271M AUM 16.93% 1-Year Est. Return
MLM
Mount Lucas Management Newtown, Pennsylvania $271M AUM 25.49% 1-Year Est. Return
PFG
Prosperity Financial Group San Ramon, California $271M AUM 30.27% 1-Year Est. Return
MCM
Moerus Capital Management New York $271M AUM 58.78% 1-Year Est. Return
RP
Ravenswood Partners Mclean, Virginia $271M AUM
PCM
Punch Card Management Winter Park, Florida $271M AUM 11.49% 1-Year Est. Return
ACH
Axis Capital Holdings Pembroke, Bermuda $270M AUM 16.26% 1-Year Est. Return
S
Siemens Munich, Germany $272M AUM 183.71% 1-Year Est. Return

Foresite Capital Management V's Q3 2025 Portfolio in Review

As of Q3 2025, Foresite Capital Management V held 6 positions worth $109M, up 35% from $80.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management V withdrew a net $3.57M in Q3 2025, reducing 1 holding. Its largest reduction was Maze Therapeutics, cutting an estimated $4.37M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Foresite Capital Management V added an estimated $804K to Lyell Immunopharma.

  • Foresite Capital Management V added most to Lyell Immunopharma in Q3 2025, an estimated $804K increase.
  • Foresite Capital Management V's biggest Q3 2025 reduction was Maze Therapeutics, cutting an estimated $4.37M.
  • Foresite Capital Management V's ten largest holdings make up 100% of its $109M portfolio in Q3 2025.
  • Foresite Capital Management V opened 0 new positions and closed 0 in Q3 2025.
  • Foresite Capital Management V's portfolio value rose 35% quarter-over-quarter to $109M.

Based on Foresite Capital Management V's 13F filing for Q3 2025, filed 14 Nov 2025.